Eli Lilly to Acquire CrossBridge Bio for ADC Platform
Houston, Texas, U.S. | April 15, 2026 Eli Lilly and Company has announced a strategic agreement to acquire CrossBridge...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Houston, Texas, U.S. | April 15, 2026 Eli Lilly and Company has announced a strategic agreement to acquire CrossBridge...
BELLEVUE, Wash., January 27, 2026 — OSR Holdings, Inc. (NASDAQ: OSRH) has completed the acquisition of Woori IO Co.,...
London, United Kingdom, January 21, 2026 — GSK has announced a $2.2 billion acquisition of RAPT Therapeutics, securing global...
Burlington, Massachusetts – October 15, 2025 – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt,...
